Global Weekly Picks

Community Contributor

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

$RKLB Investment Thesis: early mover in a fast growing industry. Likely to experience share price volatility as they scale $RKLB is a top play for exposure to a vertically integrated space company; a lot rides on the success of the Neutron rocket The Bull Case: Neutron Unlocks Scale The current Electron rocket gives $RKLB a reliable, high-cadence launch with a track record (74+ flights) and market credibility.

View narrative

US$16.25

268.7% overvalued

30.00%

Revenue growth p.a.

4.8k

Excellon Resources

Agricola

Community Contributor

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Excellon Resources Inc. is a Toronto-based mineral exploration and development company focused on silver and gold projects in Peru, the United States, and Germany.

View narrative

CA$31.8

98.5% undervalued

4.1k

Credit Corp Group

FundamentallySarcastic

Community Contributor

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Credit Corp Group Limited ASX: CCP Market Cap: AU$923.0m Weighted Average Number of Shares: 80.37m The Business CCP’s main business is acquiring portfolios of bad debts from financial institutions and collecting on them for profit. As the original lenders write off these debts, the portfolios are generally bought at a discount.

View narrative

AU$12.64

12.1% overvalued

7.00%

Revenue growth p.a.

609

Load previous narratives

Palomar Holdings

Steady Growth in Specialty Insurance with Capital Discipline

Main Driver of Recent Growth Palomar has delivered standout performance, with earnings growing ~61% YoY and revenue rising ~53% YoY , underscoring exceptional underwriting execution and demand momentum in specialty lines. How Catalysts Support the Trend Strong Q2 2025 results further reinforce momentum: revenue up 55% YoY and net income up 81% YoY ; earnings and revenues beat analyst expectations by ~16% and ~5% respectively.Read more

US$590.17

77.3% undervalued

WisetoWealth's Fair Value

Revenue

44% p.a.

Profit Margin

35%

Future PE

20.81x

Price in 2030

US$819.12

MERLIN Properties SOCIMI

The future of Merlin lies in the management of data centers.

Merlin Propiertis is a Spanish REIT with 4 lines of business: 1. Bureaux 2.Read more

€19.38

37.5% undervalued

kapirey's Fair Value

Revenue

15% p.a.

Profit Margin

90%

Future PE

20x

Price in 2030

€24.73

Tesla

Elon Musk is a scam

It's just a car company. Level 4 autonomy is not going to be achieved for now while Elon Musk continuously insinuates that Level 5 autonomy will be available soon.Read more

3.9k

US$67.45

616.6% overvalued

Friso's Fair Value

Revenue

15.66% p.a.

Profit Margin

7.3%

Future PE

25x

Price in 2030

US$109.9

Rio Tinto Group

RIO is poised to weather a depressed iron ore environment, but commodity diversification comes with lower margins

RIO strategy At a high level, RIO’s growth strategy is to diversify away from Iron ore into in-demand commodities. Specifically, copper, aluminum and lithium.Read more

2.4k

AU$110.51

29.5% overvalued

Dusty's Fair Value

Revenue

5% p.a.

Profit Margin

24%

Future PE

10.26x

Price in 2030

AU$166.84

Berger Paints Jamaica

Berger Paints Jamaica set to shine with new manufacturing expansion

Narrative for Berger Paints Jamaica Limited (BRG) Berger Paints Jamaica Limited (BRG) is a leading player in the Jamaican and regional coatings industry, with a strong legacy spanning over 72 years. The company has demonstrated resilience and adaptability through strategic investments, operational improvements, and product innovation.Read more

JA$9.82

36.6% undervalued

Sean876's Fair Value

Revenue

4.5% p.a.

Profit Margin

5.5%

Future PE

18x

Price in 2029

JA$20.11

Cybin

Cybin Set to Revolutionize Psychedelic Therapy with CYB003's Promising Results

It sounds like Cybin (CYBN) is gaining serious traction in the psychedelic therapy space! Guggenheim’s $35 price target is pretty aggressive, considering the stock is currently trading at a fraction of that.Read more

396

CA$0

n/a

Zip2420's Fair Value

Profit Margin

14.57%

Future PE

21.57x

Price in 2030

CA$0

GSK

GSK: March Madness Lineup

March Madness is here, or so they say on the basketball courts. But Marchs madness is slowly moving off to more than just the courts.Read more

742

UK£78

76.8% undervalued

DailyInvestors's Fair Value

Revenue

49.03% p.a.

Profit Margin

8.21%

Future PE

23.02x

Price in 2029

UK£103.62

Rheinmetall

Rheinmetall could get 20-25% of EU-NATO 3%-GDP defence spending

If European NATO members would raise their military spending to ~3% of their GDP, this would mean a combined yearly spending of over 500b€. Rheinmetall management assumed on 12th March 2025 that 20% to 25% of the entire military spending could be spent with Rheinmetall.Read more

7.5k

€7.57k

79.5% undervalued

Noggerno's Fair Value

Revenue

64% p.a.

Profit Margin

20%

Future PE

18x

Price in 2030

€9.57k

Pfizer

Pfizer's Future Depends on Oncology Growth, New Products and operational efficiency

I think that Pfizer has a strong pipeline. The aquisition of seagen added many new oncology products that will continue to grow by 14% partially offseting the decline on sales of the covid-19 vaccines.Read more

586